Purpose: Neck ultrasonography (NUS) is one of the most commonly used methods for evaluating thyroid nodules and preoperative higher TSH levels are known to be associated with differentiated thyroid cancers. This study was conducted to assess whether serum TSH levels and neck ultrasonography are of value in predicting malignancy in patients with atypia of undetermined significance/follicular lesions of undetermined significance (AUS). Methods: A total of 62 patients (7 men, 55 women; mean age 48.4±11.9 years) who had indeterminate cytologic results indicating AUS underwent thyroidectomy. Preoperative clinical data including serum TSH and the findings of NUS were analyzed retrospectively between malignant and non-malignant groups. Results: The final pathologic results of malignancy were reported in 53 of 62 (85.5%) patients with AUS. There was no significant difference in the mean value of preoperative serum TSH between malignant and non-malignant groups (1.5±1.3 vs. 1.9±1.2, P=NS). In NUS, the patients diagnosed with malignancy in histology showed a higher proportion of calcification, taller-than-wide shape, hypoechoic texture and irregular margin (58.5% vs. 22.2%, P=0.044; 34% vs. 0%, P=0.038; 98.1% vs. 44.4%, P＜0.01; 47.2% vs. 0%, P= 0.008). Conclusion: Serum TSH was not related to malignancy in thyroid nodules showing AUS. However, ultrasonographic features including calcifications, taller-than-wide shape, hypoechoic pattern and irregular margin could be used to predict malignancy. Ultrasonography should be the first useful methods when making decisions regarding management of thyroid nodules showing indeterminate cytologic results as AUS.
INTRODUCTION
Despite the high number of thyroid nodules in normal population, the occurrence of malignancy in population with thyroid nodules remains relatively low, ranging between 5∼7%. (1, 2) Fine needle aspiration cytology (FNAC) with or without ultrasonography guidance is an essential part of the assessment of a solitary thyroid nodule.
The Bethesda system for reporting thyroid cytopathology (BSRTC) was formulated as a means to better standardize the cytologic interpretation of thyroid lesions. (2) Table 1 shows the BSRTC and implication of risk of malignancy with recommending clinical management. The creation of a new category, atypia of undetermined significance/ The serum TSH level may be useful in not only predicting the probability of cancer but also optimizing the extent of thyroidectomy in patients with nodular thyroid disease. (22) However, the role of TSH was not fully evaluated especially in patients with AUS. Our study showed there was no difference in TSH level between malignant and benign group in patients with AUS. But the present study contained limited number of patients to evaluate the TSH level for the prediction of malignancy in AUS.
Despite the increased utilization of FNAC and ultrasound, cytologically indeterminate thyroid nodules continue to present a major diagnostic issue for clinicians. (3) Several authors have attempted to subclassify nodules based on several clinical, ultrasonographic, and cytologic characteristics to better predict malignancy in indeterminate nodules, (8, 9, 24) and should be used as an adjunct criterion in association with available clinical and radiologic criteria in order to make an accurate determination of clinical risk. (27, 28) This study, like many others addressing the same topic, has its shortcomings. This case series was limited to AUS cases with corresponding surgical intervention.
Based on our findings, clinical findings such as gender, age, tumor size, and preoperative serum TSH level have not failed to predict the malignancy in AUS of cytologic diagnosis. Otherwise, ultrasonographic features such as calcifications, taller-than-wide shape, irregular margin, and hypoechogenicity are adequately sensitive or specific
